Human CellExp™ Kallikrein-13, human recombinant

Human CellExp™ Kallikrein-13, human recombinant is available at Gentaur for Next week delivery.

Regarded as a novel cancer biomarker

Biomolecule/Target: Kallikrein-13

Alternates names: KLK13, KLKL4, KLK-13, Kallikrein-13

Synonyms: KLK13, KLKL4, KLK-13, Kallikrein-13

Background Information: Kallikrein-13 (KLK13) is also known as Kallikrein-like protein 4 (KLK-L4), is a secreted protein, belongs to the peptidase S1 family and Kallikrein subfamily. KLK-13 contains one peptidase S1 domain. KLK13 is mainly expressed in prostate, breast, testis and salivary gland. KLK13 may be involved in the pathogenesis and / or progression of breast and ovary cancers, and is regarded as a novel cancer biomarker. In addition, KLK13 interacts and forms complexes with several serum protease inhibitors, such as alpha2-macroglobulin, and its expression is regulated by steroid hormones.

Reconstitution Instructions: Centrifuge the vial prior to opening. Reconstitute in sterile PBS, pH 7.4 to a concentration of 50 µg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 month. For extended storage, it is recommended to store at -20°C.

NCBI Gene Symbol: KLK13

Gene ID: 26085

NCBI Accession: Q9UKR3